Skip to main content
. 2017 Sep 28;8(65):108676–108691. doi: 10.18632/oncotarget.21358

Figure 3. In vitro cytotoxicity of PLGA-PFOB NPs and cRGD-PLGA-PFOB NPs in BRL-3A hepatic cells.

Figure 3

Cells were treated with different concentrations of NPs for 24 h.